Enterprise Financial Services Corp (EFSC)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-47
| Closed | -$8K | – | 430 |
|
2021
Q2 | $8K | Buy |
47
+13
| +38% | +$2.21K | ﹤0.01% | 803 |
|
2021
Q1 | $5K | Hold |
34
| – | – | ﹤0.01% | 910 |
|
2020
Q4 | $5K | Buy |
34
+6
| +21% | +$882 | ﹤0.01% | 868 |
|
2020
Q3 | $4K | Hold |
28
| – | – | ﹤0.01% | 871 |
|
2020
Q2 | $4K | Buy |
28
+23
| +460% | +$3.29K | ﹤0.01% | 877 |
|
2020
Q1 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 1108 |
|
2018
Q4 | – | Sell |
-19
| Closed | -$2K | – | 980 |
|
2018
Q3 | $2K | Buy |
+19
| New | +$2K | ﹤0.01% | 890 |
|
2017
Q2 | – | Sell |
-66
| Closed | -$3K | – | 930 |
|
2017
Q1 | $3K | Buy |
+66
| New | +$3K | ﹤0.01% | 840 |
|
2016
Q1 | – | Sell |
-63
| Closed | -$6K | – | 1049 |
|
2015
Q4 | $6K | Sell |
63
-2
| -3% | -$190 | ﹤0.01% | 674 |
|
2015
Q3 | $5K | Hold |
65
| – | – | ﹤0.01% | 690 |
|
2015
Q2 | $8K | Buy |
+65
| New | +$8K | ﹤0.01% | 604 |
|